Researchers from an Italian university have tested a novel therapeutic approach to treat leukemia and lymphomas, consisting of polymeric nanoparticles (NPs) decorated with a targeting antibody and loaded with chemotherapeutic drugs. The group seeks to partner with pharmaceutical companies developing drugs and chemotherapeutics against leukemia and lymphoma. A regional grant will support the co-development of the research results by paying the costs of one year fellowship.
Submitted: May 26 2017
Updated: Jun 26 2017
Market: Animal health, Drug delivery and other equipment , Oncology , Pharmaceuticals/fine chemicals , Therapeutic services
Technology: Clinical Research, Trials, Cytology, Cancerology, Oncology , Medical Research , Micro- and Nanotechnology related to Biological sciences , Pharmaceutical Products / Drugs
NACE: Research and experimental development on biotechnology